Form 4: BioLife Solutions Executive Todd Berard Reports Stock Grants

Todd Berard, Chief Marketing Officer of BioLife Solutions, reports the acquisition of common stock grants as part of compensation.

Summary

• Todd Berard, Chief Marketing Officer of BioLife Solutions Inc., filed a Form 4 on March 20, 2025, reporting changes in beneficial ownership of the company's stock.
• On March 18, 2025, Berard acquired 19,099 shares of common stock granted under the BioLife Solutions 2023 Omnibus Performance Incentive Plan, which vest 25% on the first anniversary and then quarterly.
• Additionally, Berard acquired 20,798 shares of common stock granted under the 2013 Performance Incentive Plan, which vested at 175% based on the company's total shareholder return compared to its peers from January 1, 2023, to December 31, 2024.
• Following these transactions, Berard directly owns 144,858 shares of BioLife Solutions common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The document reports routine stock grants to an executive, which is generally a positive sign of aligning management interests with shareholders. The performance-based vesting adds a further positive element.

Positives

• The stock grants indicate confidence in the company's future performance, as they are tied to performance incentives and continued employment.
• The vesting schedule of the 2023 plan encourages long-term commitment from the executive.

Industry Context

Stock grants are a common practice in the biotech industry to incentivize executives and align their interests with those of shareholders.

Comparison to Industry Standards

• Stock grants and vesting schedules are standard components of executive compensation packages in publicly traded companies, particularly in growth-oriented sectors like biotechnology.
• The vesting terms (25% after one year, then quarterly) are fairly typical.
• Performance-based vesting, as seen in the 2013 plan grant, is also a common practice to tie executive compensation to company performance relative to peers.

Stakeholder Impact

• The stock grants align the executive's interests with those of shareholders, potentially driving long-term value creation.
• Employees may view the grants as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Grants, BioLife Solutions, BLFS, Todd Berard, Executive Compensation, Shareholder Return